Crossmark

Prognostic value of anti-IFI16 autoantibodies in pulmonary arterial hypertension and mortality in patients with systemic sclerosis

Crossref DOI link: https://doi.org/10.1016/j.medcli.2023.11.020

Published Print: 2024-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Perurena-Prieto, Janire

Callejas-Moraga, Eduardo L.

Sanz-Martínez, María T.

Colobran, Roger

Guillén-Del-Castillo, Alfredo

Simeón-Aznar, Carmen P.
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (PI16/02088, PI20/00761, PI22/01804)

European Regional Development Fund
License Information

Text and Data Mining valid from 2024-04-01

Text and Data Mining valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01

stm-asf valid from 2024-04-01
More Information

This article is maintained by: Elsevier

Article Title: Prognostic value of anti-IFI16 autoantibodies in pulmonary arterial hypertension and mortality in patients with systemic sclerosis

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2023.11.020

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.